How much chlorogenic acid does Brazilian Conilon Coffee contain per serving?

Brazilian Conilon Coffee provides at least 550 mg of chlorogenic acids per daily dose as reported in preliminary research, which is notably higher than many conventional arabica coffee preparations. This elevated chlorogenic acid content is one reason researchers have investigated this specific cultivar for antioxidant applications.

Can Brazilian Conilon Coffee help with Alzheimer's disease?

There is only preliminary evidence from a single pilot study involving 9 Alzheimer's patients who consumed Conilon Coffee for 90 days and showed some cognitive improvement alongside reduced oxidative stress markers. The study was uncontrolled and far too small to draw clinical conclusions; it should not be interpreted as proof of efficacy, and no one should replace established Alzheimer's treatments with coffee supplementation.

What is the difference between Conilon Coffee and regular robusta coffee?

Coffea canephora 'Conilon' is a specific robusta variety selectively cultivated in the Espírito Santo state of Brazil, distinguished by its particularly high chlorogenic acid concentrations relative to generic robusta or arabica beans. While standard robusta coffees also contain more caffeine and chlorogenic acids than arabica, the Conilon cultivar's phytochemical profile has been specifically characterized in oxidative stress research.

What oxidative stress markers did Brazilian Conilon Coffee reduce in studies?

In the published pilot study, daily consumption of Brazilian Conilon Coffee over 90 days reduced AOPP (advanced oxidation protein products) by approximately 37% and TBARS (thiobarbituric acid reactive substances) by approximately 60%. AOPP reflects protein oxidation driven by myeloperoxidase activity, while TBARS indicates lipid peroxidation, suggesting the coffee's chlorogenic acids may protect both proteins and lipids from oxidative damage.

How much caffeine is in Brazilian Conilon Coffee compared to regular coffee?

As a robusta-type cultivar, Conilon beans contain approximately 2.7% caffeine by dry weight, roughly double the 1.2–1.5% found in typical arabica beans used in most commercial coffee. A standard 200 mL cup prepared from Conilon may deliver 150–200 mg of caffeine, so individuals sensitive to stimulants or those taking medications metabolized by CYP1A2 should account for this higher caffeine load.

Is Brazilian Conilon Coffee safe to take with blood pressure or heart medications?

Brazilian Conilon Coffee contains caffeine and bioactive compounds that may have mild cardiovascular effects, so consultation with a healthcare provider is recommended before use with antihypertensive or cardiac medications. The high chlorogenic acid content may also interact with certain medications metabolized by the liver, making professional medical review important for those on chronic medications.

Who should avoid Brazilian Conilon Coffee supplementation?

Individuals with caffeine sensitivity, uncontrolled hypertension, anxiety disorders, or sleep disturbances should avoid or limit Brazilian Conilon Coffee due to its caffeine content. Pregnant women, nursing mothers, and children should consult healthcare providers before use, as safety data in these populations is limited.

How strong is the clinical evidence supporting Brazilian Conilon Coffee for brain health?

Current evidence is preliminary, based primarily on one pilot study with only 9 participants showing cognitive improvements in Alzheimer's disease patients. While the antioxidant and polyphenol profile is promising, larger, well-controlled clinical trials are needed to establish efficacy and determine optimal dosing for neuroprotective benefits.

Brazilian Conilon Coffee (Coffea canephora 'Conilon')

Brazilian Conilon Coffee (Coffea canephora 'Conilon') is a robusta-type cultivar grown in Espírito Santo, Brazil, containing exceptionally high concentrations of chlorogenic acids (≥550 mg per daily dose) that exert antioxidant effects by scavenging reactive oxygen species and inhibiting lipid peroxidation. Preliminary clinical evidence suggests it may reduce oxidative stress biomarkers and support cognitive function in at-risk populations.

Category: Coffee Cultivars Evidence: 2/10 Tier: Emerging

Brazilian Conilon Coffee (Coffea canephora 'Conilon') — Hermetica Encyclopedia

Origin & History

Brazilian Conilon coffee (Coffea canephora 'Conilon') is a cultivar variant of Robusta coffee primarily cultivated in Brazil's Espírito Santo state, originating from seeds collected in southern regions like Alegre and Cachoeiro de Itapemirim. It is genetically distinct with high diversity among clones selected for agronomic traits, typically roasted for beverage preparation. The beans are rich in polyphenols and methylxanthines, particularly chlorogenic acids (CGAs) and caffeine.

Historical & Cultural Context

No evidence of historical or traditional medicinal use was found for Conilon coffee. It is primarily an agricultural cultivar developed in Brazil for commercial production, with recent focus on quality and yield rather than traditional medicine applications.

Health Benefits

• Cognitive improvement in Alzheimer's disease patients (preliminary evidence from one pilot study with 9 participants)
• Reduced oxidative stress markers by 37% (AOPP) and 60% (TBARS) after 90 days (preliminary evidence)
• Antioxidant support from high chlorogenic acid content (≥550 mg per daily dose)
• Potential neuroprotective effects through polyphenol and caffeine combination (preliminary evidence)
• May support mental performance through caffeine content (≥540 mg per daily dose)

How It Works

Chlorogenic acids in Conilon Coffee, primarily 5-caffeoylquinic acid (5-CQA), inhibit the enzyme myeloperoxidase and directly scavenge reactive oxygen species, thereby reducing formation of advanced oxidation protein products (AOPP) and thiobarbituric acid reactive substances (TBARS) — two established markers of systemic oxidative damage. Caffeine and its metabolites (theophylline, theobromine) competitively antagonize adenosine A1 and A2A receptors in the central nervous system, increasing dopaminergic and cholinergic neurotransmission, which may underlie the observed cognitive effects. Additionally, chlorogenic acids may modulate Nrf2 pathway activation, upregulating endogenous antioxidant enzymes such as superoxide dismutase and glutathione peroxidase.

Scientific Research

Evidence is limited to one pilot study (PMID: 37980673) involving 9 elderly participants with Alzheimer's disease who consumed ≥2 cups of CGA-rich Conilon coffee daily for 90 days, showing cognitive improvements and reduced oxidative stress markers. No randomized controlled trials (RCTs) or meta-analyses specific to Conilon coffee were identified in the research.

Clinical Summary

The primary human evidence comes from a single pilot study of 9 participants with Alzheimer's disease who consumed Brazilian Conilon Coffee daily for 90 days, observing a 37% reduction in AOPP and a 60% reduction in TBARS alongside preliminary cognitive improvements. This sample size is critically small and the study lacked a placebo control, meaning results must be interpreted as hypothesis-generating rather than conclusive. No large randomized controlled trials have yet been published specifically on this cultivar. The antioxidant capacity findings are biologically plausible given the cultivar's documented high chlorogenic acid content, which exceeds that of many arabica varieties, but independent replication is needed.

Nutritional Profile

Brazilian Conilon Coffee (Coffea canephora 'Conilon') is characterized by a distinct bioactive compound profile compared to Arabica varieties. Key components per standard daily dose (approximately 2-3 cups or ~200-300 mL brewed): Caffeine: 60-120 mg per 100 mL brewed (notably higher than Arabica, typically 25-40% more caffeine by dry weight, ~2.7% caffeine in green bean dry weight vs ~1.5% in Arabica). Chlorogenic Acids (CGAs): ≥550 mg per daily dose as documented in clinical use; predominantly 5-caffeoylquinic acid (5-CQA), 3-CQA, and 4-CQA, plus dicaffeoylquinic acids (diCQAs); Conilon tends to have higher CGA concentrations than Arabica (range 7-10% dry weight in green beans vs 5-7% in Arabica). Trigonelline: ~0.5-1.0% dry weight (precursor to niacin/Vitamin B3 upon roasting; bioavailability is moderate and roast-dependent). Melanoidins (from roasting): 25% of roasted bean dry weight approximately; contribute to antioxidant activity and prebiotic-like fiber effects. Diterpenes (Cafestol and Kahweol): present at lower levels in filtered preparations; unfiltered/espresso preparations may contain 2-5 mg per cup; Conilon contains primarily cafestol with minimal kahweol compared to Arabica. Protein: approximately 10-13% of green bean dry weight; largely degraded during roasting, with negligible protein content in brewed coffee (<0.1 g per 100 mL). Carbohydrates: minimal in brewed form (<1 g per 100 mL); green beans contain sucrose (~6-8% dry weight) largely degraded during roasting to form melanoidins and Maillard reaction products. Lipids: ~8-12% of green bean dry weight (Robusta/Conilon slightly lower than Arabica); largely retained in bean, minimal in filtered brewed coffee. Minerals per 200 mL brewed: Potassium ~70-100 mg (good bioavailability), Magnesium ~6-10 mg, Calcium ~2-5 mg, Manganese ~0.05-0.1 mg, trace Zinc and Iron. Niacin (Vitamin B3): approximately 0.5-1.0 mg per cup derived from trigonelline conversion during roasting; bioavailability estimated at 40-60%. Bioavailability notes: CGAs are partially absorbed in the small intestine (24-72% absorption depending on matrix and gut microbiome); colonic fermentation by microbiota converts remaining CGAs to phenylpropionic acids and ferulic acid, extending antioxidant activity. Caffeine bioavailability is high (>95% absorption). CGA bioavailability may be enhanced by the specific polyphenol matrix of Conilon due to its high diCQA content. Roast level significantly impacts CGA content: light roasts preserve ≥80% of CGAs while dark roasts may reduce content by 50-70%; clinical studies showing ≥550 mg CGA per daily dose likely use light-to-medium roast preparations.

Preparation & Dosage

In the sole human study, participants consumed ≥2 cups (≥400 mL) of brewed Conilon coffee daily, delivering ≥550 mg chlorogenic acids and ≥540 mg caffeine. No standardized extract forms or powder dosages have been studied. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, Ginkgo biloba, Alpha-GPC, Rhodiola rosea

Safety & Interactions

Conilon Coffee contains significant caffeine (robusta beans typically carry 2.7% caffeine by dry weight, roughly double that of arabica), posing risks of insomnia, elevated heart rate, and anxiety at high doses, particularly in caffeine-sensitive individuals. It may interact with anticoagulants such as warfarin by inhibiting CYP1A2-mediated drug metabolism, and may potentiate the effects of stimulant medications including amphetamines and ephedrine. Chlorogenic acids can mildly inhibit iron absorption when consumed with meals, a relevant consideration for individuals with iron-deficiency anemia. Pregnant and breastfeeding women should limit total caffeine intake to below 200 mg/day per major health guidelines, and should consult a physician before using concentrated coffee-derived supplements.